MS
RMD icon

Maven Securities’s ResMed RMD Stock Holding History

Maven Securities’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-14,600
Closed -$2.79M – 1048
2024
Q2 		$2.79M Buy
+14,600
New +$2.96M 0.06% 300
2023
Q2 		– Sell
-2,300
Closed -$504K – 1022
2023
Q1 		$504K Buy
+2,300
New +$499K 0.01% 656
2021
Q3 		– Sell
-1,000
Closed -$247K – 1241
2021
Q2 		$247K Buy
+1,000
New +$210K 0.01% 884

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Maven Securities's RMD Position: Q3 2025 in Review

Maven Securities sold out of ResMed (RMD) in Q3 2025, closing a stake of 3,386 shares — an estimated $869K sold.

Maven Securities first reported a position in RMD in Q2 2025 and held it in 1 quarter. The position peaked at $869K in Q2 2025. 949 funds tracked by Wall St. Rank hold RMD as of Q3 2025.

  • Maven Securities reported no remaining ResMed position as of Q3 2025 after selling out during the quarter.
  • Maven Securities sold 3,386 ResMed shares in Q3 2025, an estimated $869K.
  • Maven Securities first reported a position in ResMed in Q2 2025 and held it in 1 quarter.
  • Maven Securities's ResMed position peaked at $869K in Q2 2025.
  • 949 funds tracked by Wall St. Rank held ResMed as of Q3 2025.

Based on Maven Securities's 13F filing for Q3 2025, filed 20 Nov 2025.